| Losartan Alleviates Renal Fibrosis and Inhibits Endothelial-to-Mesenchymal Transition (EMT) Under High-Fat Diet-Induced Hyperglycemia | |
| Yao, Yufeng; Li, Yong; Zeng, Xiaofei; Ye, Zheng; Li, Xia; Zhang, Lu | |
| 刊名 | FRONTIERS IN PHARMACOLOGY
 |
| 2018 | |
| 卷号 | 9 |
| 关键词 | EMT diabetic nephropathy TGF-beta 1/Smad signaling losartan oxidative stress |
| ISSN号 | 1663-9812 |
| DOI | 10.3389/fphar.2018.01213 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4213363 |
| 专题 | 武汉大学 |
| 推荐引用方式 GB/T 7714 | Yao, Yufeng,Li, Yong,Zeng, Xiaofei,et al. Losartan Alleviates Renal Fibrosis and Inhibits Endothelial-to-Mesenchymal Transition (EMT) Under High-Fat Diet-Induced Hyperglycemia[J]. FRONTIERS IN PHARMACOLOGY,2018,9. |
| APA | Yao, Yufeng,Li, Yong,Zeng, Xiaofei,Ye, Zheng,Li, Xia,&Zhang, Lu.(2018).Losartan Alleviates Renal Fibrosis and Inhibits Endothelial-to-Mesenchymal Transition (EMT) Under High-Fat Diet-Induced Hyperglycemia.FRONTIERS IN PHARMACOLOGY,9. |
| MLA | Yao, Yufeng,et al."Losartan Alleviates Renal Fibrosis and Inhibits Endothelial-to-Mesenchymal Transition (EMT) Under High-Fat Diet-Induced Hyperglycemia".FRONTIERS IN PHARMACOLOGY 9(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论